Last reviewed · How we verify

Placebo caplet of Metformin XR

Dexa Medica Group · Phase 3 active Small molecule

Placebo caplet of Metformin XR is a Small molecule drug developed by Dexa Medica Group. It is currently in Phase 3 development for Control arm in Phase 3 clinical trial of Metformin XR. Also known as: Placebo caplet of Glumin XR.

This is a placebo formulation with no active pharmacological mechanism.

This is a placebo formulation with no active pharmacological mechanism. Used for Control arm in Phase 3 clinical trial of Metformin XR.

At a glance

Generic namePlacebo caplet of Metformin XR
Also known asPlacebo caplet of Glumin XR
SponsorDexa Medica Group
ModalitySmall molecule
Therapeutic areaDiabetes
PhasePhase 3

Mechanism of action

A placebo caplet contains no active pharmaceutical ingredient and produces no direct pharmacological effect. It is used as a control in clinical trials to assess the efficacy of the active Metformin XR formulation by comparison. Any observed effects are attributable to placebo response rather than drug action.

Approved indications

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Placebo caplet of Metformin XR

What is Placebo caplet of Metformin XR?

Placebo caplet of Metformin XR is a Small molecule drug developed by Dexa Medica Group, indicated for Control arm in Phase 3 clinical trial of Metformin XR.

How does Placebo caplet of Metformin XR work?

This is a placebo formulation with no active pharmacological mechanism.

What is Placebo caplet of Metformin XR used for?

Placebo caplet of Metformin XR is indicated for Control arm in Phase 3 clinical trial of Metformin XR.

Who makes Placebo caplet of Metformin XR?

Placebo caplet of Metformin XR is developed by Dexa Medica Group (see full Dexa Medica Group pipeline at /company/dexa-medica-group).

Is Placebo caplet of Metformin XR also known as anything else?

Placebo caplet of Metformin XR is also known as Placebo caplet of Glumin XR.

What development phase is Placebo caplet of Metformin XR in?

Placebo caplet of Metformin XR is in Phase 3.

Related